Literature DB >> 10475254

Lipopolysaccharide of Escherichia coli, polyamines, and acetic acid stimulate cell proliferation in intestinal epithelial cells.

J Olaya1, V Neopikhanov, A Uribe.   

Abstract

Our aim was to examine whether lipopolysaccharide of Escherichia coli, polyamines of dietetic and/or bacterial origin, and products of the bacterial metabolism influence cell proliferation in epithelial cells from the colon and small intestine. Lipopolysaccharide of Escherichia coli 0111:B4 was incubated with cultures from human colonic mucosa. The mitoses were arrested with Vincristine and the total number of metaphases per crypt was counted. In addition, lipopolysaccharide was incubated with a human colonic epithelial cell line from adenocarcinoma (LS-123 cells) and with a nontransformed small intestinal cell line from germ-free rats (IEC-6 cells) for 24 h. In the last 4 h, the cells were labeled with tritiated thymidine. The cells were incubated with putrescine, cadaverine, and spermidine at 10(-11)-10(-3) M and with acetic acid (10(-5)-10(-1) M), acetaldehyde (10(-10)-10(-4) M) and ammonium chloride (1-20 mM). Lipopolysaccharide of Escherichia coli increased the number of arrested metaphases in human colonic crypts and DNA synthesis in L-123 and IEC-6 cells (P < 0.001). All polyamines increased DNA synthesis in the colonic and small intestinal cell lines, the effects being more marked for putrescine (P < 0.001). The higher concentrations of acetic acid increased DNA synthesis in both epithelial cell lines (P < 0.001). Acetaldehyde slightly decreased DNA synthesis in LS-123 cells at cytotoxic concentrations. Ammonium chloride did not significantly affect DNA synthesis. The final concentration of nonionized ammonia was less than 3%. It is concluded that lipopolysaccharides of Escherichia coli and intraluminal factors derived from microorganisms increase cell proliferation in human colonic crypts and intestinal epithelial cell lines.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10475254     DOI: 10.1007/s11626-999-0042-4

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  25 in total

1.  Helicobacter pylori stimulates DNA synthesis in a small intestinal cell line in vitro.

Authors:  J Brännström; K Zachrisson; K Hultén; L Engstrand; A Uribe
Journal:  Digestion       Date:  1998       Impact factor: 3.216

2.  Effect of sodium butyrate on mammalian cells in culture: a review.

Authors:  K N Prasad; P K Sinha
Journal:  In Vitro       Date:  1976-02

Review 3.  The role of inflammatory mediators in the pathogenesis of periodontal disease.

Authors:  R C Page
Journal:  J Periodontal Res       Date:  1991-05       Impact factor: 4.419

4.  Endotoxin and lipid A stimulate proliferation of human T cells in the presence of autologous monocytes.

Authors:  T Mattern; A Thanhäuser; N Reiling; K M Toellner; M Duchrow; S Kusumoto; E T Rietschel; M Ernst; H Brade; H D Flad
Journal:  J Immunol       Date:  1994-10-01       Impact factor: 5.422

5.  The influence of antibiotics upon microflora-associated characteristics in man and mammals.

Authors:  T Midtvedt; A Bjørneklett; B Carlstedt-Duke; B E Gustafsson; T Høverstad; E Lingaas; K E Norin; H Saxerholt; M Steinbakk
Journal:  Prog Clin Biol Res       Date:  1985

6.  Endogenous prostaglandins and microflora modulate DNA synthesis and neuroendocrine peptides in the rat gastrointestinal tract.

Authors:  A Uribe; M Alam; T Midtvedt; B Smedfors; E Theodorsson
Journal:  Scand J Gastroenterol       Date:  1997-07       Impact factor: 2.423

7.  Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis.

Authors:  W Kruis; E Schütz; P Fric; B Fixa; G Judmaier; M Stolte
Journal:  Aliment Pharmacol Ther       Date:  1997-10       Impact factor: 8.171

8.  Microflora-derived polyamines modulate obstruction-induced colonic mucosal hypertrophy.

Authors:  D L Osborne; E R Seidel
Journal:  Am J Physiol       Date:  1989-06

9.  Administration of Escherichia coli endotoxin to rat increases liver mass and hepatocyte volume in vivo.

Authors:  D Qian; J T Brosnan
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

10.  Effect of short-chain fatty acids on the human colonic mucosa in vitro.

Authors:  W Scheppach; P Bartram; A Richter; F Richter; H Liepold; G Dusel; G Hofstetter; J Rüthlein; H Kasper
Journal:  JPEN J Parenter Enteral Nutr       Date:  1992 Jan-Feb       Impact factor: 4.016

View more
  5 in total

1.  Chorioamnionitis-induced fetal gut injury is mediated by direct gut exposure of inflammatory mediators or by lung inflammation.

Authors:  Tim G A M Wolfs; Boris W Kramer; Geertje Thuijls; Matthew W Kemp; Masatoshi Saito; Monique G M Willems; Paranthaman Senthamarai-Kannan; John P Newnham; Alan H Jobe; Suhas G Kallapur
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-01-23       Impact factor: 4.052

2.  Potential of Omega-3 Polyunsaturated Fatty Acids in Managing Chemotherapy- or Radiotherapy-Related Intestinal Microbial Dysbiosis.

Authors:  Yue Zhang; Boyan Zhang; Lihua Dong; Pengyu Chang
Journal:  Adv Nutr       Date:  2019-01-01       Impact factor: 8.701

3.  Influence of spermine on intestinal maturation of the glycoprotein glycosylation process in neonatal rats.

Authors:  S Greco; I Hugueny; P George; P Perrin; P Louisot; M C Biol
Journal:  Biochem J       Date:  2000-01-01       Impact factor: 3.857

4.  Cadaverine, a metabolite of the microbiome, reduces breast cancer aggressiveness through trace amino acid receptors.

Authors:  Tünde Kovács; Edit Mikó; András Vida; Éva Sebő; Judit Toth; Tamás Csonka; Anita Boratkó; Gyula Ujlaki; Gréta Lente; Patrik Kovács; Dezső Tóth; Péter Árkosy; Borbála Kiss; Gábor Méhes; James J Goedert; Péter Bai
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

5.  Jejunoileal mucosal growth in mice with a limited microbiome.

Authors:  Matthew P Shaughnessy; Christine J Park; Pooja S Salvi; Robert A Cowles
Journal:  PLoS One       Date:  2022-03-29       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.